Vice President, Business Development
Agustin de la Calle, PhD
Dr. Agustin de la Calle is a biotech executive with over 20 years of global experience in business development, partnerships, and fundraising. He has led strategic deals and investor outreach contributing to multiple IPOs and over $1B in value creation. His track record includes successful fundraising rounds with VCs, corporate investors, and cross-border partners.
Agustin earned his Ph.D. from Freie Universität Berlin, conducting research at Dana-Farber Cancer Institute and Harvard Medical School, and completed postdoctoral studies at MIT. At AiViva, he supports global partnering and strategic growth across the pipeline and JEL® platform.